RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-27 4:16 pm Purchase | 2025-06-25 | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 1,986,993 31.800% | 1,500 (+0.08%) | Filing |
| 2024-12-30 6:51 pm Purchase | 2024-12-26 | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 1,985,493 31.900% | 846,476 (+74.32%) | Filing |
| 2023-08-11 5:05 pm Purchase | 2023-08-10 | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 1,139,017 33.700% | 1,010 (+0.09%) | Filing |
| 2022-12-09 4:31 pm Purchase | 2022-12-07 | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 1,138,007 34.800% | 581,442 (+104.47%) | Filing |
| 2022-11-14 4:46 pm Purchase | 2022-11-10 | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 556,565 28.780% | 516 (+0.09%) | Filing |